Theodore Kee

JPMorgan | Forbes U30 | Digital health/Mental Health | Korean-American

[Theodore Kee @TheodoreKee]

@JinYueming @BME_NUS Welcome to the fu30 family!

[Theodore Kee @TheodoreKee]

@thedeanh @SingaporeAir @WeAreWisDM @TheN1Institute @BME_NUS @NUSingapore Whenever I mention my mentor. This is the pic I’m sending people now lol 💪🏼 gym session meetings!

[Theodore Kee @TheodoreKee]

@VenmoSupport did Venmo crash? My account got completely wiped and can’t see recent transactions or anything! There was a good chunk of money in there too. This is ridiculous

[Theodore Kee @TheodoreKee]

Inspirational and passing on the good will to others in the community!

[Dean Ho @thedeanh]

Two years ago today, my colleagues saved my wife’s life. Since then, each day has been a gift. You are all family. Today, we’re announcing the @TheN1Institute Patient Impact Fund. Seeded with a personal contribution, we will cover medical costs for patients in Singapore.1/

[Theodore Kee @TheodoreKee]

@AlexandriaRemus It allows journals to prevent multiple back to back automatic submissions. Any slips in formatting shows to them which other journal you mightve submitted to before and gotten rejected from. Smart tactic tbh

[Theodore Kee @TheodoreKee]

Shoutout to @MicronTech for the $500k gift towards @TheN1Institute efforts using https://t.co/xDNf8sqUNt to identify (🤯 how punny) optimised therapies against #COVID19! #WeAreN1

[Dean Ho @thedeanh]

Our team @TheN1Institute received a $500,000+ gift from the Micron Foundation to optimise actionable therapies against COVID-19 with https://t.co/WJb2cYHnGA. We’re deeply grateful for the support and look forward to helping as many patients as possible. Stay Tuned. #WeAreN1

[Theodore Kee @TheodoreKee]

@v_e_e_e_e @shortiey422 @thedeanh Wouldve been fun to take yall around the sights, noona! Will definitely make it worth the delay when you come visit!

[Theodore Kee @TheodoreKee]

@CEI_org @TheN1Institute @wellcometrust Pleasure is ours also!

[Theodore Kee @TheodoreKee]

Proud to have co-led this proposal to @wellcometrust with @TheN1Institute with @thedeanh @AgataBlasiak Xavier @AlexandriaRemus and Acceset with Matt Oon, especially with #mentalhealth being a prominent issue in youth and even affecting us during COVID-19 and worldwide lockdown!

[Dean Ho @thedeanh]

Our team @TheN1Institute is proud to partner with Acceset to develop new #digitalhealth strategies to address #mentalhealth, and we are deeply appreciative to the Wellcome Trust for supporting our efforts. Shout out to Matt Oon, @TheodoreKee @AgataBlasiak and the N.1 crew!

[Theodore Kee @TheodoreKee]

@TheN1Institute @JasonKWLee @NUSMedicine Our resident Commando!

[Theodore Kee @TheodoreKee]

Putting the Art in STEAM! Team effort with @darron_miya @thedeanh @AgataBlasiak at @TheN1Institute to bring #AI to life AIDAN & AI-LIN to fight a #COVID19 like infectious disease, Vinny the Virus! Download for free at: https://t.co/xOHLpNulQP
#WeAreN1

[Theodore Kee @TheodoreKee]

@RishiDesaiMD @thedeanh @AgataBlasiak @AlexandriaRemus @echow310 @TheN1Institute @OsmosisMed Most definitely time for a trial!

[Theodore Kee @TheodoreKee]

Congrats to @AgataBlasiak for the clinical trial abstract at #AACR20. Great virtual presentation and narration on using CURATEAI to help patients with multiple myeloma. #WeAreN1

[Dean Ho @thedeanh]

Our team @TheN1Institute is privileged to present our clinical trial abstract at #AACR20. We’re harnessing #CURATE.AI for novel trial designs to help patients with multiple myeloma. Proud to be part of an amazing team! #WeAreN1

[Dean Ho @thedeanh]

Excited to publish our first results from Project IDentifAI, which used #AI to optimise combination therapy against infectious diseases (ID), within days.
We need to move beyond traditional drug repurposing and screening. There’s a way to optimize both. https://t.co/8vzpM7PIt0

[Theodore Kee @TheodoreKee]

Honoured to be inducted into the Forbes 30 Under 30 Asia! It’s amazing to be highlighted for our work in the various clinical trials and projects with https://t.co/qeWnxQm6zR and digital therapeutics to improve patient lives!
#ForbesUnder30 #theN1InstituteforHealth #NUS #WeAreN1

[Theodore Kee @TheodoreKee]

Having just done a podcast myself, shoutout to @thedeanh for highlighting AI in medicine and its myriad of applications!
@TheN1Institute @BME_NUS @AgataBlasiak @AlexandriaRemus

[Dean Ho @thedeanh]

Had a super fun time podcasting with Dr @taimurbaigdbs, Chief Economist and Managing Director at DBS Bank on the use of #AI to address cancer, COVID-19, and many other healthcare challenges! (📷: Courtesy of DBS/Dr. Taimur Baig/Martin Tacchi). https://t.co/MIMXN4hSin

[Theodore Kee @TheodoreKee]

Podcast with @AgataBlasiak and David Pechter from @SLAS_Org. Listening to myself is another level of cringe

[Agata Blasiak @AgataBlasiak]

There is also a podcast where @TheodoreKee and me talk about https://t.co/QCwpMrs2D0 : https://t.co/kgtsB2CZPc
The interviewer, David Pechter, has the best podcast voice! @SLAS_Org @TheN1Institute

[Theodore Kee @TheodoreKee]

Our review on personalised dosing with https://t.co/qeWnxQm6zR and optimised combination dosing with QPOP. First corresponding authorship with my work partner in crime, @AgataBlasiak! @TheN1Institute @thedeanh @BefferyBonk

[Agata Blasiak @AgataBlasiak]

It is a cover! Thank you @SLAS_Org for selecting our review on personalised dosing with https://t.co/QCwpMrs2D0 for a cover of the April issue of SLAS Technology! @TheN1Institute @TheodoreKee @thedeanh

[Agata Blasiak @AgataBlasiak]

I’ve got an email from my former PhD funder @AXAResearchFund about #OpenCovid19 initiative https://t.co/3EfKZmrqwI . @thedeanh and @TheodoreKee immediately agreed we can allow our coders to dedicate 2d/week to it in the next month! Proud to be part of @TheN1Institute #Covid_19 💪

[Science Magazine @ScienceMagazine]

Cancer therapy involves different stages, including drug discovery, development, and administration. #AI is poised to benefit each stage but is also confronted by challenges that, when overcome, may lead to practice-changing treatment. https://t.co/OtZVJ5icwL #SciMagPerspective